Assessment and treatment of depressive disorders in adults with ADHD

Author(s):  
Jefferson B. Prince
1988 ◽  
Vol 18 (1) ◽  
pp. 167-177 ◽  
Author(s):  
Greg Wilkinson

SynopsisA videotape-assisted simulated consultation model was used in a pilot study comparing a range of assessment and treatment decisions made by trainee general practitioners and trainee psychiatrists in response to two cases representing women with depressive disorders. The doctors were studied individually in their consulting rooms or offices. In relation to the methods of analysis chosen, levels of agreement within and between the two groups of trainees were generally low. The findings are discussed in relation to previous similar work undertaken with experienced clinicians studied in groups.


1993 ◽  
Vol 27 (2) ◽  
pp. 254-263 ◽  
Author(s):  
Henry Brodaty ◽  
Lynne Harris ◽  
Kay Wilhelm ◽  
Ian Hickie ◽  
Philip Boyce ◽  
...  

Specialist treatment centres, such as the Mood Disorders Unit (MDU) at Prince Henry Hospital, Sydney, have developed in response to the high prevalence of mood disorders and their frequent persistence and treatment resistance. The MDU's assessment and treatment of patients from state-wide catchment area and its teaching and research effectiveness are reviewed. Of 479 patients assessed between 1985 and 1989, there were 304 with primary depressive disorders, of whom 154 were followed up by clinical assessment at 52 weeks and 231 by telephone interview at 3 1/2 years. At intake, 59% were tertiary referral patients and 88% were from outside the local area. Two-thirds were recovered 3 1/2 years later, despite the disorders having been generally severe and protracted. Treatment modality was associated primarily with diagnosis, but also with age and somewhat with the patient's personality and consultant psychiatrists' preferences. No consistent predictors of outcome were discerned. Specialist tertiary referral centres, such as the MDU, contribute significantly to treatment success, especially of difficult cases, and enrich teaching and research.


Author(s):  
Diana Joyce-Beaulieu ◽  
Brian Zaboski

Thousands of students in the United States suffer from anxiety and depressive disorders, many of which may be ameliorated with early intervention and evidenced-based treatment. At the same time, complete student wellness requires a consideration of both pathology and well-being. Using a dual-factor model, this chapter reviews the symptoms, resilience factors, and functional impairments associated with anxiety and depression. Recommendations for early identification, assessment, and treatment—including psychoeducation, mindfulness, and behavioral techniques—are discussed within a multitiered system of supports. Special consideration is provided to address suicide prevention and intervention. Practical recommendations and techniques for school-based practitioners are offered, in addition to assessment measures and technology resources.


Author(s):  
C. Steven Richards ◽  
Michael W. O'Hara

In this chapter, we provide a brief introduction to our book. We discuss the following themes, which run throughout this edited book on depressive disorders and comorbidity: assessment and diagnosis, theory and methods, psychiatric comorbidity, health comorbidity, relationship comorbidity, intervention and consultation, and future directions. A number of themes will be apparent, including the incredibly broad scope of depressive comorbidity. Depression goes with many other problems. Another theme is that the specifics of depressive comorbidity—and the implications for theory, research, and practice—vary considerably as we consider one type of comorbidity versus another. For example, the comorbidity of depression and generalized anxiety disorder has very different implications than the comorbidity of depression and alcohol-use disorder, which in turn is different than the comorbidity of depression and cancer, which again has different implications than the comorbidity of depression and severe relationship dysfunction. Each of the chapters in the book highlight some of the themes and issues, but the remarkable breadth and depth of depressive comorbidity becomes clearer as we consider all of the chapters in total. We attempt to bridge some of these differences and look for common themes in the Epilogue at the end of the book, as do some of the contributors in their individual chapters on specific issues or types of comorbidity. In this Introduction, however, we focus more on the specific chapters and a few of the themes that are highlighted in each one. Overarching themes, such as what is meant bycomorbidity, how might future efforts at assessment and treatment be improved, and what future developments may be particularly helpful are discussed in many of the individual chapters. This brief introduction serves to highlight a few of the issues and introduce the reader to the broad array of chapters that await them in the rest of the book.


2015 ◽  
Vol 17 (2) ◽  
pp. 219-227 ◽  

Diagnosis and treatment of comorbid neuropsychiatric illness is often a secondary focus of treatment in individuals with autism spectrum disorder (ASD), given that substantial impairment may be caused by core symptoms of ASD itself. However, psychiatric comorbidities, including depressive disorders, are common and frequently result in additional functional impairment, treatment costs, and burden on caregivers. Clinicians may struggle to appropriately diagnose depression in ASD due to communication deficits, atypical presentation of depression in ASD, and lack of standardized diagnostic tools. Specific risk and resilience factors for depression in ASD across the lifespan, including level of functioning, age, family history, and coping style, have been suggested, but require further study. Treatment with medications or psychotherapy may be beneficial, though more research is required to establish guidelines for management of symptoms. This review will describe typical presentations of depression in individuals with ASD, review current information on the prevalence, assessment, and treatment of comorbid depression in individuals with ASD, and identify important research gaps.


Sign in / Sign up

Export Citation Format

Share Document